Renal Drugs Market expansion is driven by the growing burden of diabetes and hypertension, which are major risk factors associated with chronic kidney disease. The Renal Drugs Market was valued at US$ 21.16 billion in 2025 and is projected to reach US$ 35.05 billion by 2034, registering a CAGR of 5.77% during the forecast period from 2026 to 2034. Market growth is supported by the increasing...